Arterial Remodeling Technologies develops fully resorbable coronary polymer stents intended to promote natural remodeling of an injured artery after angioplasty. The technology is based on intellectual property originating from the Cleveland Clinic, CNRS (Montpellier) and Descartes University (Paris). The company is based in Noisy le Roi, France. On 21 September 2010 it closed an $8.5M new venture financing round. That financing brought the total capital raised by the company to date to $17M. Investors in the round included existing backers Matignon Technologies and Amundi Private Equity Funds and new partner InnoBio Fund (managed by CDC Entreprises).

Total raised

$9M

Funding rounds

1

Latest round

Equity

Latest activity

Sep 2010